SMART Trial: Community Stigma Reduction

NCT ID: NCT05075330

Last Updated: 2022-03-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

199 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-16

Study Completion Date

2021-08-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this project is to engage community members from two low-income African American communities (N=200) in a survey study that assesses stigma toward those with Opioid Use Disorder (OUD). Those from the intervention community will be subject to a stigma reduction campaign via billboards. Those from the control community will not. Stigma will be re-assessed following the period of the campaign.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Opioid-use Disorder Stigma, Social

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Participants assigned to intervention or control based on zip code of primary residence.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Participants who live in the Orange Mound community of Memphis. Billboards targeting stigma reduction were posted in the community for one month.

Group Type EXPERIMENTAL

Opioid Use Disorder Stigma Reduction

Intervention Type BEHAVIORAL

Billboards with destigmatizing language regarding opioid use disorder placed in the community.

Control

Participants who live in the Frayser community of Memphis. No billboards (intervention) were placed here.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Opioid Use Disorder Stigma Reduction

Billboards with destigmatizing language regarding opioid use disorder placed in the community.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Identify as African American or Mixed race
* Reside in Frayser or Orange Mound Communities
* Access to telephone for follow-up assessment

Exclusion Criteria

* Unable to understand consent procedures
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Center for Complementary and Integrative Health (NCCIH)

NIH

Sponsor Role collaborator

Karen Derefinko, PhD

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Karen Derefinko, PhD

Associate Professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Karen Derefinko, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Tennessee

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Tennessee Health Science Center

Memphis, Tennessee, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

21-08181-XP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Healthy Opioid Prescription Engagement
NCT05141266 ACTIVE_NOT_RECRUITING NA
OUD Smartphone Services
NCT06134882 RECRUITING NA
HEALing Communities Study
NCT04111939 ACTIVE_NOT_RECRUITING NA
Minds and Mentors Program- R33
NCT05363371 RECRUITING NA
Cannabis and Opioid Use Disorder
NCT05729932 RECRUITING PHASE1